Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. (symbol: MIR) is a leading provider of radiation detection, measurement, analysis, and monitoring products and services. Mirion serves a diverse range of markets including nuclear power, medical, military, and homeland security, ensuring the safety of people, property, and the environment from nuclear and radiological hazards for over 50 years.
Headquartered in the San Francisco Bay Area, Mirion operates facilities across Europe, Asia, and North America, making it a globally recognized entity in the realm of radiation safety solutions. The company is structured into two main segments:
- Medical Segment: This segment focuses on radiation oncology quality assurance, providing critical patient safety solutions in diagnostic imaging and radiation therapy centers. Mirion’s advanced technologies ensure precise and reliable results, significantly enhancing patient care and safety.
- Technologies Segment: Catering to nuclear energy, defense, laboratories, scientific research, and other industrial markets, this segment represents the largest portion of the company’s revenue. Mirion's products and services in this segment are vital for accurate measurement and analysis in high-stakes environments, contributing to scientific advancements and industrial safety.
Mirion Technologies’ recent achievements include the development of cutting-edge radiation detection tools and strategic partnerships aimed at enhancing global safety standards. The company’s commitment to innovation is underscored by its continuous investment in R&D, resulting in reliable and advanced products that meet the evolving needs of its diverse clientele.
Financially, Mirion Technologies has demonstrated solid performance, with a robust revenue stream primarily driven by the Technologies segment. The company’s global presence, coupled with its specialized expertise, positions it as a critical player in the fields it serves.
Mirion Technologies (NYSE: MIR) is hosting an Investor Day at the New York Stock Exchange to present its updated strategic and financial outlook. The company projects revenue of $1.1 billion by 2028, with 6-8% organic revenue growth, and targets an adjusted EBITDA margin of 30%. For 2025, Mirion forecasts organic revenue growth of 5.5-7.5% and adjusted EBITDA of $215-230 million. The company highlights its position in nuclear power and cancer care markets, announcing an anti-dilutive share repurchase program and updated capital allocation strategy. Management will discuss market opportunities in nuclear power growth, cancer care dynamics, and operational excellence initiatives.
Mirion Technologies (NYSE: MIR) has announced its participation in the Goldman Sachs' Industrials and Materials Conference in New York. CEO Thomas Logan and CFO Brian Schopfer will deliver a presentation on Thursday, December 5, 2024, at 10:40 AM ET. The event will be accessible via live webcast on Mirion's Investor Relations Page under the 'Events and Presentations' section, with an archived version available afterward.
Mirion (NYSE: MIR) reported Q3 2024 results with revenues increasing 8.2% to $206.8 million. Despite a net loss of $14.0 million, the company showed improved operational performance with Adjusted EBITDA rising 17.8% to $45.7 million and margin expanding to 22.1%. Adjusted EPS reached $0.08, up from $0.05 year-over-year.
The company updated its FY2024 guidance, raising revenue growth expectations to 6-7% and organic growth to 5-6%. Mirion maintains its Adjusted EBITDA target of $195-205 million and Adjusted EPS of $0.37-0.42, while tightening its adjusted free cash flow range to $65-75 million.
Mirion Technologies (NYSE: MIR) has secured two major contracts for the Sizewell C nuclear power station project in the UK. The first contract, awarded in October 2024, covers Electrical Penetration Systems (EPS) for secure cable passage through reactor containment walls. The second contract, from May 2024, is for Boron Meter Systems to measure boron concentration in water. The 3.2-gigawatt Sizewell C facility will mirror Hinkley Point C's design and generate low-carbon electricity for approximately 6 million homes.
Mirion Technologies (NYSE: MIR) has announced its upcoming Investor Day scheduled for December 3, 2024, at 2:00 p.m. ET at the New York Stock Exchange. The event will feature presentations from key leadership, including CEO Thomas Logan on radiation safety strategy, CFO Brian Schopfer on financial outlook, Technologies Group President Loic Eloy on nuclear innovations, and Medical Group EVP Luis Rivera on cancer care developments.
The event will be webcast live, with in-person attendance to invited institutional investors and financial analysts who must register by November 18, 2024. Interested parties can access the webcast through the company's IR website or via a dedicated registration link.
Mirion Technologies (NYSE: MIR) has announced its schedule for the release of third quarter 2024 financial results. The company will disclose its earnings after the market closes on Tuesday, October 29, 2024. Following this, Mirion will host a conference call on Wednesday, October 30, 2024, at 11:00 am ET to discuss the results in detail.
Interested parties can join the call by dialing 1-877-407-9208 (US) or 1-201-493-6784 (international). A live webcast will be available on the company's investor relations website. For those unable to attend, a telephonic replay will be accessible until November 13, 2024, using the access code 13749095.
Varian, a Siemens Healthineers company, and Sun Nuclear, a Mirion Medical company (NYSE: MIR), have announced an alliance to expand Varian's quality assurance (QA) offerings for radiotherapy solutions. Under the agreement, Varian will sell Sun Nuclear's SunCHECK® quality management platform across its sales channels, broadening QA support for its treatment delivery solutions.
Sun Nuclear, a market leader in radiation oncology quality management, has solutions used in over 6,000 cancer treatment facilities. The alliance aims to enhance clinical workflows, improve treatment outcomes, and ease radiation therapy technology adoption. Varian will continue to support existing QA customers while expanding its comprehensive QA offerings.
As part of the agreement, Varian and Sun Nuclear will also enhance the integration of QA software for future radiotherapy offerings, reinforcing Varian's commitment to excellence in patient care and safety.
Mirion (NYSE: MIR) reported Q2 2024 financial results with revenues increasing 5.0% to $207.1 million. The company saw a net loss of $12.0 million, an improvement from $28.4 million loss in Q2 2023. Adjusted EBITDA rose 10.2% to $48.8 million, with margin expanding to 23.6%. Mirion raised its full-year adjusted EBITDA guidance to $195-$205 million while reiterating 5-7% revenue growth and $0.37-$0.42 adjusted EPS guidance. The company also announced a strategic nuclear new build partnership with EDF, strengthening its position in the nuclear market.
Mirion Technologies (NYSE: MIR) has announced its schedule for the release of second quarter 2024 financial results. The company will disclose its earnings after market close on Thursday, August 1, 2024, followed by a conference call on Friday, August 2, 2024, at 11:00 am ET to discuss the results.
Investors and analysts can participate in the call by dialing 1-877-407-9208 (US) or 1-201-493-6784 (international). A live webcast will be available on the company's investor relations website. For those unable to attend, a telephonic replay will be accessible until August 16, 2024, using the access code 13747541.
Mirion (NYSE: MIR) has announced a change in timing for its management team's presentation at the Jefferies’ 2024 Global Healthcare Conference. The presentation will now start at 3:30 PM ET on Thursday, June 6, 2024. The event will be webcast live on Mirion's investor relations website under the 'Events and Presentations' section. An archived version of the webcast will be accessible within twelve hours after the event concludes.
FAQ
What is the current stock price of Mirion Technologies (MIR)?
What is the market cap of Mirion Technologies (MIR)?
What does Mirion Technologies do?
Where is Mirion Technologies headquartered?
What are the main segments of Mirion Technologies?
What markets does the Technologies segment serve?
Which segment generates the most revenue for Mirion Technologies?
How long has Mirion Technologies been in operation?
In which regions does Mirion Technologies have facilities?
What is the focus of the Medical segment?
What recent achievements has Mirion Technologies made?
How does Mirion Technologies contribute to scientific research?
